Riskpilot← Back to searchSign inGet full accessTMOS HOLDING AS
ASActiveOrg 912014169Camilla Colletts Veg 31, 2407 ElverumWholesale of pharmaceutical and medical goods · NACE 4646Est. 20130 employees
Revenue 2024
NOK 62K
-63% vs 2023
EBITDA margin
-129.8%
-16% vs 2023
Equity ratio
-10203.0%
Financial strength
Net profit 2024
NOK -294K
+65% vs 2023
| Revenue | NOK 62K | -63% |
| EBITDA | NOK -80K | -16% |
| Net profit | NOK -294K | +65% |
| Total assets | NOK 9K | -97% |
| Equity | NOK -947K | -45% |
| Employees | 0 | — |
Legal name
TMOS HOLDING AS
Org number
912014169
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juni 2013
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Engroshandel med sykepleie- og apotekvarer og konsulentvirksomhet i tilknytning til dette, samt å delta i andre selskap med lignende virksomhet ved kjøp og salg av aksjer.
Address
Camilla Colletts Veg 31, 2407 Elverum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 254 | 190 | 180 | 168 | 62 |
| Staff expenses | −0 | −20 | −0 | −0 | −0 |
| EBITDA | 178 | 143 | −32 | −69 | −80 |
| Depreciation & amort. | −82 | −82 | −82 | −27 | −0 |
| EBIT | 95 | 61 | −115 | −97 | −80 |
| Net financials | −7 | 0 | −43 | −746 | −213 |
| Profit before tax | 89 | 61 | −158 | −842 | −294 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 89 | 61 | −158 | −842 | −294 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 514 | 1 649 | 1 243 | 339 | 9 |
| Equity | 286 | 347 | 189 | −653 | −947 |
| Long-term debt | 306 | 306 | 194 | 126 | 66 |
| Short-term debt | 922 | 996 | 861 | 867 | 891 |
| Total debt | 1 228 | 1 302 | 1 054 | 992 | 956 |
EBITDA margin
-129.8%
This company
15.8%
Market median
-922% vs market
20202024
Equity ratio
-10203.0%
This company
38.2%
Market median
-26809% vs market
20202024
Return on equity
-29372800.0%
This company
18.4%
Market median
-159634883% vs market
20202024
Net profit margin
-473.8%
This company
8.1%
Market median
-5949% vs market
20202024
Asset turnover
6.68×
This company
1.12×
Market median
+496% vs market
20202024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
HK Deputy Member | Deputy Member | 2015 – 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
| Former (1) | ||
| Chairman | 2015 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TMOS HOLDING AS 
GETWELL HEALTHCARE ASBoard members of TMOS HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanne Kristin Blådammen | Deputy Member | 0 companies |
| Tore Martin Olden Stensberg | Chairman | 0 companies |
| Tore Martin Stensberg | Chairman | 0 companies |